211 related articles for article (PubMed ID: 18932013)
1. Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.
Ibañez-Cuevas V; Lopez-Briz E; Guardiola-Chorro MT;
Pharm World Sci; 2008 Dec; 30(6):947-54. PubMed ID: 18932013
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
[TBL] [Abstract][Full Text] [Related]
3. Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.
López-Pintor E; Lumbreras B
Int J Clin Pharm; 2011 Apr; 33(2):155-64. PubMed ID: 21394571
[TBL] [Abstract][Full Text] [Related]
4. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study.
MacFarlane B; Matthews A; Bergin J
Int J Clin Pharm; 2015 Oct; 37(5):851-6. PubMed ID: 25972205
[TBL] [Abstract][Full Text] [Related]
5. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
6. Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care.
Lanas A; Plazas MA; Gimeno E; Muñoz-Tudurí M
Gastroenterol Hepatol; 2012 Jan; 35(1):1-7. PubMed ID: 22178503
[TBL] [Abstract][Full Text] [Related]
7. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers.
Lallana MJ; Feja C; Aguilar-Palacio I; Malo S; Rabanaque MJ
Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149590
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
9. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM
Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants.
Tielemans MM; van Rossum LG; Eikendal T; Focks JJ; Laheij RJ; Jansen JB; van Oijen MG
Int J Clin Pract; 2014 Apr; 68(4):512-9. PubMed ID: 24499203
[TBL] [Abstract][Full Text] [Related]
12. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes.
van Leen MW; van der Eijk I; Schols JM
Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
14. Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients.
Pai AB
J Am Pharm Assoc (2003); 2015; 55(1):e15-23; quiz e24-5. PubMed ID: 25503987
[TBL] [Abstract][Full Text] [Related]
15. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
16. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study.
Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C
J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387
[TBL] [Abstract][Full Text] [Related]
17. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Thomas J; Straus WL; Bloom BS
Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of pharmacists' interventions with nonsteroidal antiinflammatory drugs.
Guignard AP; Couray-Targe S; Colin C; Chamba G
Ann Pharmacother; 2003 Mar; 37(3):332-8. PubMed ID: 12639158
[TBL] [Abstract][Full Text] [Related]
19. Assessing student pharmacist impact on patient over-the-counter medication selection.
McConaha JL; Finoli LM; Heasley JE; Lunney PD
J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist Counseling and the Use of Nonsteroidal Anti-Inflammatory Drugs by Older Adults.
Bear MD; Bartlett D; Evans P
Consult Pharm; 2017 Mar; 32(3):161-168. PubMed ID: 28270271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
